A concentrated fish oil that has been converted back from the ethyl ester intermediate into a triglyceride, so the fatty acids sit on a glycerol backbone as they do in fish.
Concentrating fish oil requires converting it to ethyl esters first; re-esterification is the extra manufacturing step that converts it back. The bioavailability comparison has actually been done: in a controlled two-week study, re-esterified triglyceride raised the omega-3 index by roughly a quarter more than natural fish oil triglyceride, while the ethyl ester delivered about three-quarters as much. That is a genuine difference and it is also a modest one — smaller than the difference between taking a capsule with a fatty meal and taking it fasted, and much smaller than the difference between a 300 mg and a 900 mg EPA+DHA serving.
Sold as
Softgel, Liquid oil
Standardised to
Labelled "rTG" or "triglyceride form"; mg EPA and DHA per serving still the relevant figure — a product without this marker may not resemble what was studied.
Also known as
rTG omega-3, Triglyceride-form fish oil, Re-esterified fish oil
Regulation: Sold as a dietary supplement in the US with no pre-market efficacy or safety review. There is no legal definition of the marketing terms used to distinguish these forms, so label wording is no assurance about the manufacturing route.
What the research used
The amounts, forms and durations published trials of Re-esterified triglyceride omega-3 actually administered.
These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.
Studied for Bioavailability comparison
1.7 g
Moderate
EPA+DHA daily as rTG, natural TG or ethyl ester · 2 weeks
Relative to natural fish oil triglyceride set at 100%, re-esterified triglyceride reached roughly 124% and ethyl ester roughly 73% of the increase in the omega-3 index. Doses in outcome trials are set by EPA+DHA content, not by form.
Studied for General use
0.5–4 g
Moderate
EPA+DHA daily
Dose targets are the same as for any marine oil, because every outcome trial in the field is defined by EPA+DHA delivered rather than by chemical form.
This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.
When it was taken
Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.
Each timing below was actually compared against an alternative in a trial, which is unusual.
🍽️With food
Moderate
The food effect is real for all forms but largest for ethyl esters. Triglyceride-form oils are less dependent on a fatty meal, which is one practical reason to prefer them, and this has been measured directly rather than assumed.
Timing was tested. A trial compared this window against another and reported a difference.
The evidence in depth
Best supported: Moderate
What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.
The triglyceride-lowering effect belongs to EPA and DHA, and re-esterified oil delivers slightly more of them per labelled milligram than an ethyl ester does. No outcome trial has compared forms on a clinical endpoint, so the advantage is an absorption finding rather than a health finding.
Moderate evidence. Several human studies point the same way, with real caveats.
Every large cardiovascular outcome trial of omega-3 used either an ethyl ester or a carboxylic acid preparation. There is no outcome evidence specific to re-esterified triglyceride oils, and inferring one from absorption data is a step beyond what has been shown.
Not enough evidence. Not enough human research to say anything useful yet.
No source is attached to this association yet, so it is rated not enough evidenceby default. It is listed because people commonly ask about it — not because there is evidence for it.
Things to know
Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.
Interaction
Bleeding risk with anticoagulants and antiplatelets
Interacts withWarfarin, direct oral anticoagulants, antiplatelet drugs
Identical to any other marine omega-3 at equivalent EPA+DHA dose. Form changes absorption, not pharmacology.
Worth knowing
The form premium is often oversold
The measured absorption advantage over natural triglyceride oil is modest, and is easily outweighed by choosing a product with more EPA+DHA per serving or by taking it with a meal. Price per gram of EPA+DHA is the more useful comparison.
Worth knowing
Oxidation still applies
Re-esterification does not protect against rancidity. Independent testing has found oxidised product across all chemical forms.